Autopsy report · NCT00495053

Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

“Slow enrollment and financial issues”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 2 years 7 months before it stopped.
• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Urovant Sciences GmbH

Sponsor type

Industry

Conditions

Overactive Bladder

Interventions

hMaxi-K; Placebo

Participants

21

Sites

1

Countries

United States

Trials that died the same way

• Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
  “Slow enrollment and financial constraints.” (94% match in meaning)
• Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
  “Slow enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.